Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Toxicol Lett 220(2):143149
It is not a prescription GLP-1 medication, does not contain semaglutide or tirzepatide and should not replace medically necessary treatment
[2] Liraglutide (Saxenda) is indicated in combination with a reduced calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in people aged twelve years of age and older with body weight greater than 60 kilograms (130 lb) and obesity
Medical distributors, stockists, and pharma professionals interested in cardiovascular and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiac segment.
Trial participation provides access to investigational treatments while contributing to the evidence base that ultimately benefits all Canadians
US$ 29.50
US$ 29.66
US$ 25.06
